Rationale for combination therapy of chronic myelogenous leukemia with imatinib and irradiation or alkylating agents: Implications for pretransplant conditioning

被引：0

作者：

Fruehauf, S ^{[1
]}

Topaly, J ^{[1
]}

Schad, M ^{[1
]}

Ho, A ^{[1
]}

Zeller, W ^{[1
]}

机构：

[1] Univ Heidelberg, D-6900 Heidelberg, Germany

来源：

EXPERIMENTAL HEMATOLOGY | 2002年 / 30卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

224

引用

页码：92 / 92

页数：1

共 50 条

[1] Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning
Topaly, J
Fruehauf, S
Ho, AD
Zeller, WJ
BRITISH JOURNAL OF CANCER, 2002, 86 (09) : 1487 - 1493
[2] Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning
J Topaly
S Fruehauf
A D Ho
W J Zeller
British Journal of Cancer, 2002, 86 : 1487 - 1493
[3] The biology of chronic myelogenous leukemia: Implications for imatinib therapy
Alvarez, Ricardo H.
Kantarjian, Hagop
Cortes, Jorge E.
SEMINARS IN HEMATOLOGY, 2007, 44 (01) : S4 - S14
[4] Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia
Tauchi, T
Ohyashiki, K
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (05) : 434 - 440
[5] Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
Tetsuzo Tauchi
Kazuma Ohyashiki
International Journal of Hematology, 2004, 79 : 434 - 440
[6] Imatinib Therapy in Chronic Myelogenous Leukemia
Jinnai, Itsuro
INTERNAL MEDICINE, 2007, 46 (02) : 95 - 97
[7] Specific targeted therapy of chronic myelogenous leukemia with imatinib
Deininger, MWN
Druker, BJ
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 401 - 423
[8] Resistance to imatinib in chronic myelogenous leukemia: Mechanisms and clinical implications
La Rosée P.
Hochhaus A.
Current Hematologic Malignancy Reports, 2008, 3 (2) : 72 - 79
[9] Imatinib therapy in chronic myelogenous leukemia:: strategies to avoid and overcome resistance
Hochhaus, A
La Rosée, P
LEUKEMIA, 2004, 18 (08) : 1321 - 1331
[10] Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia
Barton, JC
Jones, SC
Lamberth, WC
Reymann, MT
Scott, VC
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (02) : 139 - 140

← 1 2 3 4 5 →